This startup provides concierge kidney care that focuses on delaying the progression of chronic kidney disease (CKD) to end-stage renal disease (ESRD) through personalized treatment plans. By increasing the adoption of home-based dialysis, the company enhances patient outcomes and expands eligibility for kidney transplantation.
Funding
$477.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with chronic kidney disease (CKD) often experience a decline in kidney function that progresses to end-stage renal disease (ESRD), requiring dialysis or kidney transplantation. Managing CKD and related conditions such as congestive heart failure (CHF) requires coordinated care and patient support to slow disease progression and improve outcomes. Traditional care models often lack the integration and personalization needed to address the complex needs of these patients, leading to higher costs and lower quality of life.
Solution
Somatus provides a value-based care model focused on managing kidney disease, cardiovascular disease, and related comorbidities through personalized support and integrated care teams. The company's approach involves local, hands-on health support teams that partner with patients and their doctors to provide individualized clinical, emotional, and social support. Somatus leverages its proprietary RenalIQ platform, which uses AI-driven predictive analytics and machine learning algorithms to identify patients at risk of rapid disease progression and deliver insights to care team members and providers. By extending the reach of practices into the home and optimizing performance in value-based care arrangements, Somatus aims to improve patient outcomes, reduce hospital admissions and readmissions, and lower the total cost of care.
Target Audience
The primary target audience includes health plans and providers seeking to improve outcomes and reduce costs for patients with chronic kidney disease, congestive heart failure, and related comorbid conditions.
Features
- AI-driven technology platform (RenalIQ) utilizing multiple data sets and patent-pending machine learning technology
- Predictive analytics and machine learning algorithms to identify patients at risk of rapid disease progression or adverse events
- Telehealth and virtual care application for remote patient engagement
- Executive scorecards and reports providing detailed insights into network performance and cost drivers
- Patient portal (mySomatus) for online access to care plans, health information, and communication with the care team
- Multi-disciplinary care teams providing in-home assessments, medication reconciliation, and health coaching
- Support for navigating and removing social determinants of health (SDOH) barriers to care
- Integration with provider practices to extend their reach into the home and improve quality of care delivery